Lipum in consortium being granted research funding by KKS
Press release: Umeå, 5 May 2022. Lipum AB (publ) is one of the partners contributing to the KKS-Synergy grant application “Drug discovery targeting inflammation – novel therapeutic aspects on vascular inflammation, thrombosis and breast cancer” that has been granted by the Swedish Knowledge foundation (KKS).Lipum is member of the consortium together with both industry and academic partners. The project is led by the Cardiovascular Research Centre (CVRC) at Örebro University that was granted 10 million SEK from the Swedish Knowledge foundation (KKS). The total project budget is at least 26.9